Methotrexate Pfizer

Methotrexate, the active ingredient in Methotrexate Pfizer, is an antimetabolite (folate antagonist) presented as a pharmaceutical preparation for intra‑arterial, intramuscular, and intrathecal administration. It is employed in the management of rheumatoid arthritis, severe psoriasis, acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease across adult and pediatric patient groups. It is used under specialist supervision to optimise therapeutic outcomes while monitoring toxicity.

GNH USA supplies Methotrexate Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies, and clinics worldwide, adhering to rigorous quality‑assurance standards.

Methotrexate is an antimetabolite used to modulate immune activity and inhibit malignant cell proliferation.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell turnover and plaque formation. - Acute lymphoblastic leukemia: interferes with leukemic cell DNA synthesis. - Osteosarcoma: limits tumor growth by blocking folate pathways. - Gestational trophoblastic disease: induces remission by targeting proliferative trophoblastic tissue.

Methotrexate can cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting. - Fatigue or malaise. - Oral mucosal ulceration (mouth sores). - Elevated liver enzymes. - Mild to moderate cytopenias (low blood counts).

Serious or Rare Side Effects: - Severe hepatotoxicity or liver fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Life‑threatening infections due to immunosuppression. - Bone marrow failure or aplastic anemia. - Acute renal impairment.

When prescribing or handling Methotrexate, several safety considerations are essential.

- Pregnancy: contraindicated (Category X); avoid use in pregnant patients. - Renal function: assess baseline and monitor; adjust or discontinue if renal impairment worsens. - Liver function: regularly check hepatic enzymes; discontinue if significant toxicity occurs. - Hematologic monitoring: perform frequent blood counts to detect cytopenias early. - Concomitant NSAIDs: use with caution as they may increase methotrexate toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methotrexate interacts with several medicines that can alter its efficacy or safety.

Major Interactions (Avoid): - Live vaccines: avoid due to heightened infection risk. - Trimethoprim‑sulfamethoxazole: may cause severe myelosuppression. - NSAIDs: can increase methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Azathioprine: monitor for additive immunosuppression. - Alcohol: limit intake to reduce liver injury risk.